article thumbnail

23andMe announces major Workforce Reduction amid Financial Struggles

Digital Health Global

Leadership Turmoil Recently, the entire board of directors resigned following a dispute with CEO Anne Wojcicki over the company’s strategic direction. This leadership crisis has added to the uncertainty surrounding the company’s future. This risk brings concerns about the future of the genetic data it holds for millions of customers.

article thumbnail

MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members

Healthcare IT Today

.” Healthcare industry veteran Lisa Suennen , Managing Partner at American Heart Association Ventures, also joined MDisrupt’s Board of Directors, bringing decades of leadership experience and a proven track record in health innovation to support MDisrupt’s continued growth. MDisrupt has raised $6.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BioscienceLA Launches Leadership Catalyst Program For Emerging Leaders in the Life Sciences

Digital Health Global

–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors.

article thumbnail

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical

Health Populi

For the former, Amazon leadership is talking up the company’s expertise in consumer experience and delight, efficiency and engagement (which I addressed in yesterday’s Day 1 post ). To be sure, it’s both.

article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.

article thumbnail

New Tech Tonics Podcast – Carolyn Magill – May the Fast, Steep Road Rise Up to Meet You!

Digital Health

She has now traveled through the worlds of pharma, payers, providers and had leadership positions at companies both large and small. […]. But it wasn’t until she found herself at the nexus of healthcare and public policy that she realized she found her home.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients.